Delivery Order SPE2DB24D2101-SPE2DB25FKLPL
- Not listed
- The Defense Logistics Agency has awarded a delivery order valued at $17,135.28 to AmerisourceBergen Drug Corp for the supply of Orencia 250 mg vials, a pharmaceutical product used in the treatment of rheumatoid arthritis and other autoimmune conditions. This firm fixed price, competitively awarded contract was executed on July 24, 2025, with an ultimate completion date of July 25, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award is unencumbered by...
- The Defense Logistics Agency awarded a delivery order valued at $2,855.88 to AmerisourceBergen Drug Corp for the supply of Orencia 250 mg vials, a biologic medication commonly used to treat rheumatoid arthritis and other autoimmune conditions. This competitively awarded, firm fixed-price delivery order is scheduled for completion by July 23, 2025, and represents performance from AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. The contract carries no set-aside...
- The Defense Logistics Agency awarded a delivery order valued at $7,139.70 to AmerisourceBergen Drug Corp for 250 mg vials of Orencia, a biologic immunosuppressant medication commonly used to treat rheumatoid arthritis and other autoimmune conditions. Issued on August 4, 2025, with an ultimate completion date of August 5, 2025, this firm fixed-price delivery order was awarded competitively without set-aside restrictions. The contract will be performed at AmerisourceBergen's corporate office...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Orencia 250 mg vials, a biologic immunosuppressant medication used primarily for rheumatoid arthritis treatment. This firm fixed price delivery order, valued at $6,942.46, represents a non-competitive award under an existing contract vehicle and is scheduled for completion by August 26, 2025. The award was placed with AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $14,110.96 to AmerisourceBergen Drug Corp for the supply of Orencia ClickJect 125 mg/mL, a pharmaceutical product used in the treatment of rheumatoid arthritis and other autoimmune conditions. This firm fixed-price, non-set-aside delivery order was awarded on July 28, 2025, with an ultimate completion date of July 29, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a...
- The Defense Logistics Agency awarded a delivery order valued at $15,055.82 to AmerisourceBergen Drug Corp for Orencia ClickJect 125 mg/mL, a pharmaceutical product used in the treatment of rheumatoid arthritis and other autoimmune conditions. This firm fixed price delivery order was awarded on June 2, 2025, with an ultimate completion date of June 3, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a non-competitive, non-set-aside...
- The Defense Logistics Agency awarded a delivery order valued at $83,196.81 to AmerisourceBergen Drug Corp for Orencia ClickJect 125 mg/mL, a pharmaceutical product used in the treatment of rheumatoid arthritis and other autoimmune conditions. This firm fixed-price delivery order, awarded on August 11, 2025, represents a non-set-aside competitive award and is expected to reach completion by August 12, 2025. The place of performance is located at AmerisourceBergen's corporate office in...
- The Defense Logistics Agency awarded a $39,105.45 firm fixed price delivery order to AmerisourceBergen Drug Corp for Orencia ClickJect 125 mg/mL, a pharmaceutical product used in the treatment of rheumatoid arthritis and other autoimmune conditions. The award, issued on August 18, 2025, with an ultimate completion date of August 19, 2025, represents a non-competitive delivery order under a larger contract vehicle. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is one...
- The Defense Logistics Agency awarded a delivery order valued at $20,761.43 to AmerisourceBergen Drug Corp for Orencia ClickJect 125 mg/ml, a pharmaceutical product used in the treatment of rheumatoid arthritis and other autoimmune conditions. The contract is a firm fixed price delivery order with no set-aside designation, awarded competitively on June 2, 2025, with an ultimate completion date of June 3, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken,...
- The Defense Logistics Agency awarded a $4,635.46 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Orencia ClickJect 125 mg/mL, a pharmaceutical product used in the treatment of rheumatoid arthritis and other autoimmune conditions. This non-set-aside contract represents a firm fixed-price delivery order with an ultimate completion date of July 29, 2025, and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award...
- SPE2DB24D2101Indefinite Delivery Contract
- SPE2DB24D2101-SPE2DB25FKLPLDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $4,290.07 to AmerisourceBergen Drug Corp for the supply of Orencia 250 mg vials, a pharmaceutical product used in the treatment of rheumatoid arthritis and other autoimmune conditions. This competitively awarded, firm fixed-price delivery order was issued on June 18, 2025, with an ultimate completion date of June 20, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award carries no set-aside designation, indicating open competition among qualified vendors. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This comprehensive pharmaceutical prime vendor contract enables AmerisourceBergen to supply an extensive range of medications, vaccines, and medical supplies to support military healthcare operations worldwide. The company serves as a critical vendor for the Defense Health Agency and other federal healthcare systems, leveraging its position as a major pharmaceutical distributor to fulfill the Department of Defense's pharmaceutical procurement requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.3k | 6/18/25 |